23 December 2019 There are some corrections in the original article, Page 11, /LYXUMIA word has to be removed from the section RATIONALE FOR COMBINATION THERAPY COMPRISING GLP-1 RAs AND BASAL INSULIN
Cyanocobalamin: Properties and Clinical Applications Cyanocobalamin is a top choice for Vitamin B12 injections
[1] [2] This extended half-life provides some metabolic benefit during short interruptions but also means that side effects may persist for several weeks after discontinuation
Chen Q, Zheng L, Zhang Y, Huang X, Wang F, Li S, et al
Therefore, the sponsors concluded that clinically significant DDIs mediated by direct inhibition of CYP enzymes or transporters are unlikely to occur with the administration of GLP-1 RAs and a dual GLP-1/GIP RA